Biotest AG (Biotest), a subsidiary of Grifols SA, provides pharmaceutical and biotherapeutic drugs. It develops, manufactures and distributes biological medicines through its value chain from preclinical and clinical development to sales. Its main products include clotting factors, immunoglobulins, albumin and monoclonal antibodies in clinical development. The company specializes in the areas of clinical immunology, haematology and intensive care medicine. Biotest distributes its products through local marketing partners and distributors in Europe, North America, South America, Asia, the Middle East, and Africa. It has subsidiaries and sales companies in Austria, Switzerland, France, Great Britain, Italy, Hungary and Spain and Brazil. Biotest is headquartered in Dreieich, Hessen, Germany.
Headquarters
Germany
Address
Landsteinerstr. 5, Dreieich, Hessen, 63303
Website
www.biotest.com
Telephone
49 6103 8010
No of Employees
2,307
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
BIO (ETR)
Revenue (2022)
$542.7M
6.5%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
50.1%
(2022 vs 2021)
Market Cap*
$1.6B
Net Profit Margin (2022)
XYZ
50.2%
(2022 vs 2021)
* As of and is in US$
Biotest AG premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Pharmaceuticals: | Haemonine |
| Plasma Proteins | Haemoctin |
| Immunoglobins | Cytotect |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2023 | Contracts/Agreements | In April, the company strengthened its partnership with Grifols S.A. in the field of research & development, manufacturing, operations as well as sales and distribution. |
| 2023 | Corporate Changes/Expansions | In April, the company opened plasma collection centre in Munster, Westphalia, Germany. |
| 2023 | Corporate Changes/Expansions | In April, the company opened its 12th plasma collection centre in Hungary. |
Competitor Comparison
| Key Parameters | Biotest AG | Takeda Pharmaceutical Co Ltd | Celltrion Inc | Halozyme Therapeutics Inc | Stratec SE |
|---|---|---|---|---|---|
| Headquarters | Germany | Japan | South Korea | United States of America | Germany |
| City | Dreieich | Chuo-Ku | Incheon | San Diego | Birkenfeld |
| State/Province | Hessen | Tokyo | - | California | Rheinland-Pfalz |
| No. of Employees | 2,307 | 49,095 | 1,074 | 393 | 1,512 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Michael Ramroth, Ph.D. | Chief Executive Officer | Senior Management | - | 62 |
| Ainhoa Mendizabal | Chief Financial Officer | Senior Management | 2023 | 51 |
| Peter Janssen | Chief Operating Officer | Senior Management | 2022 | 57 |
| Jorg Schuttrumpf | Chief Scientific Officer | Senior Management | 2022 | 49 |
| Bernhard Ehmer | Chairman | Non Executive Board | 2022 | 68 |
| Non Dignissim Eros | Proin vel | Convallis | 2023 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2023 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2023 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward